MG
EW icon

Marex Group’s Edwards Lifesciences EW Stock Holding History

Marex Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519K Buy
5,738
+2,643
+85% +$221K ﹤0.01% 689
2026
Q1 		$248K Sell
3,095
-1,047
-25% -$86.3K ﹤0.01% 838
2025
Q4 		$353K Sell
4,142
-1,655
-29% -$136K ﹤0.01% 656
2025
Q3 		$451K Sell
5,797
-264
-4% -$20.6K ﹤0.01% 516
2025
Q2 		$474K Buy
6,061
+1,579
+35% +$118K ﹤0.01% 381
2025
Q1 		$325K Sell
4,482
-328
-7% -$23.5K 0.01% 433
2024
Q4 		$356K Buy
+4,810
New +$337K 0.01% 418
2024
Q1 		– Sell
-3,176
Closed -$242K – 567
2023
Q4 		$242K Buy
+3,176
New +$221K 0.01% 431

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Marex Group's EW Position: Q2 2026 in Review

Marex Group increased its Edwards Lifesciences (EW) stake by 85% in Q2 2026, buying an estimated $221K and bringing the position to 5,738 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Marex Group first reported a position in EW in Q4 2023 and has held it in 8 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Marex Group held 5,738 shares of Edwards Lifesciences worth $519K as of Q2 2026.
  • Marex Group bought 2,643 Edwards Lifesciences shares in Q2 2026, an estimated $221K.
  • Edwards Lifesciences made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #689 holding.
  • Marex Group first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 8 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.